The Benchmark Company downgraded AeroClean Technologies from Buy to Hold
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/14/2022 | Buy → Hold | The Benchmark Company | |
| 2/1/2022 | Speculative Buy | Benchmark |
Healthcare Technology Expert To Lead Targeted Sales Efforts For FDA-Cleared Germicidal UV-C Air Hygiene Technology PALM BEACH GARDENS, Fla., June 08, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company and producer of patented UV-C LED technology inside its innovative Pūrgo™ air purification device, announces Jimmy Thompson has joined the Company as Vice President of Strategic Sales. The addition of Thompson to the AeroClean team is a strategic investment to support core business and revenue growth within targeted industry verticals. Along with driving sales initiatives, Thompson will also be focused on dev
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life going, today announced the appointment of Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors (the "Board"). On May 11, 2022, the Board appointed Mr. Scannell as a new director on the Board, chair of the Nominating and Corporate Governance Committee and a member of the Compensation Committee. Mr. Scannell brings over 30 years of experienc
Transaction Highlights Creates a pro forma company with a substantial base of revenues, a solid balance sheet and a path to profitability.A broad range of highly complementary, proprietary and patented, FDA-cleared air purification devices.Powerful brand value and recognition with an installed base of over 350,000 air purification units, providing a foundation for growing recurring revenues from both consumables and the launch of a SaaS software solution to enable facility managers to monitor and control individual room air quality on an enterprise wide basis.Expected double-digit organic revenue growth for the combined company, with gross profit expected to grow faster than revenues due to
SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)
SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)
SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)
The Benchmark Company downgraded AeroClean Technologies from Buy to Hold
Benchmark initiated coverage of AeroClean Technologies with a rating of Speculative Buy
Establishes an industry-leading provider of premium, FDA-cleared air purification products and solutionsPositions the combined company to selectively pursue additional value-creating M&A opportunities within the broader indoor air quality ("IAQ") and cleantech industriesPowerful brand value and large installed base of over 350,000 air purification units creates an opportunity to drive recurring revenues through consumables and the launch of a software solution to monitor and control air quality on an enterprise-wide basisRecent developments include the release of Molekule's PECO-HEPA Tri-Power Filter for Air Pro, Air Mini+ and Air Mini; AeroClean's Pūrgo™ air purifier receiving FDA clearance
Additional Testing Being Performed to Confirm Elimination of Influenza and RSV PALM BEACH GARDENS, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today announced that, the U.S. Food and Drug Administration ("FDA") has granted AeroClean 510k clearance (K223328) to update its Pūrgo™ air purifier's ("Pūrgo™") indications for use to include the elimination of SARS-CoV-2, the RNA virus that causes COVID-19. The FDA has reviewed the laboratory performance data and confirmed the applicability of Pūrgo to remove SARS-CoV-2 from the air in indoor environments. The clearance adds SARS-CoV-2 to th
PALM BEACH GARDENS, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today reported financial results for the three and nine months ended September 30, 2022 ("Q3 2022"). Third Quarter 2022 Highlights and Recent Developments The Company entered into a definitive agreement with Molekule, Inc. ("Molekule"), a market leader for premium air purifiers, to combine in an all-stock merger that the Company believes will establish a combined company as a market leader for premium, FDA-cleared air purification products, and solutions.Molekule recently began collaboration with key customers across th
4 - Molekule Group, Inc. (0001872356) (Issuer)
4 - Molekule Group, Inc. (0001872356) (Issuer)
4 - Molekule Group, Inc. (0001872356) (Issuer)
25-NSE - Molekule Group, Inc. (0001872356) (Subject)
8-K - Molekule Group, Inc. (0001872356) (Filer)
8-K - Molekule Group, Inc. (0001872356) (Filer)